FR EN

Back


14/01/2015
Orphazyme, a pharma company, raises 20 million Euro in a Series B financing round
Orphazyme ApS today announced the successful completion of a 20 million Euro Series B financing round. Kurma Partners and Idinvest Partners join the existing investor syndicate of Novo A/S, Sunstone Capital and Aescap Venture.




X

X

X